Mask Investments DuPont analysis

·UnclassifiedChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.77×0.70×0.73×0.75×0.75×
−5.03×−0.59×1.08×0.63×0.77×
−10.4%−139.8%10.6%6.0%33.3%
0.00×0.00×0.00×0.01×0.00×
1.01×1.01×1.01×1.01×1.01×
0.0%0.0%0.0%0.0%0.0%
0.1%0.1%0.0%0.0%0.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MASKINVEST₹127.33

Mask Investments Limited

· Unclassified
₹ CrorePeersDANGEEKSHITIJPOLLFICAKASHSAGARDEEPAHLADAJAIPURKURTMITTALMcap ₹38.9 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.750.730.700.77
Interest Burden (Pretax/EBIT) ×0.770.631.08-0.59-5.03
EBIT Margin %33.336.0210.63-139.78-10.35
Asset Turnover ×0.000.010.000.000.00
Financial Leverage (Assets/Equity) ×1.011.011.011.011.01
ROE (5-step product, year-end total equity) %0.000.030.000.000.00
ROE (owners' profit / average owners' equity) %0.060.020.030.070.07
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.